companydata.dkNovo Nordisk Invest 4 A/S: Financial statements 2025
CVR: 31853923
Novo Nordisk Invest 4 A/S (CVR 31853923) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -64,000 and a net result of DKK -23,000 compared with DKK 7,000 the year before. Equity amounted to DKK 1,772,000. The solvency ratio was 96.4%.
- Gross Profit
- -64,000 kr.
- Profit/Loss
- -23,000 kr.
- Equity
- 1,772,000 kr.
- Total Assets
- 1,839,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -64 t. | -23 t. | 1.8 mio. | 0 |
| 2024 | - | -55 t. | 7 t. | 1.8 mio. | - |
| 2023 | - | -53 t. | 5 t. | 1.8 mio. | - |
| 2022 | - | -6 t. | 4 t. | 1.8 mio. | - |
| 2021 | - | - | -37 t. | 1.8 mio. | - |
Find more companies like Novo Nordisk Invest 4 A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of December 8, 2025, Naja Eilers Barrisøe has joined the board of directors of Novo Nordisk Invest 4 A/S.
As of December 8, 2025, Karsten Munk Knudsen has left the board of directors of Novo Nordisk Invest 4 A/S.
Novo Nordisk Invest 4 A/S has published its annual report for 2024. Gross profit came to DKK -55,000, and the net result was DKK 7,000.
About Novo Nordisk Invest 4 A/S
Novo Nordisk Invest 4 A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2008. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named STENO DIABETES CENTER A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK -64,000 and a net result of DKK -23,000 compared with DKK 7,000 the year before. Equity amounted to DKK 1,772,000.